Observational studyRheumatology (Oxford, England)2023

Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis.

Ryan M Hum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.